| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Danielle Diniz Aguiar, J\\xc3\\xbalia Alvarenga Petrocchi, Grazielle Caroline da Silva, Virg\\xc3\\xadnia Soares Lemos, Marina Gomes Miranda E Castor, Andrea de Castro Perez, Igor Dimitri Gama Duarte, Thiago Roberto Lima Romer. Participation of the cannabinoid system and the NO/cGMP/K Neuroscience letters. 2023-10-28. PMID:37898181. |
participation of the cannabinoid system and the no/cgmp/k it has already been shown that serotonin can release endocannabinoids at the spinal cord level, culminating in inhibition of the dorsal horn. |
2023-10-28 |
2023-11-08 |
Not clear |
| G M Mandolini, M Lazzaretti, A Pigoni, L Oldani, G Delvecchio, P Brambill. Pharmacological properties of cannabidiol in the treatment of psychiatric disorders: a critical overview. Epidemiology and psychiatric sciences. vol 27. issue 4. 2018-11-06. PMID:29789034. |
findings to date suggest that (a) cbd may exert antipsychotic effects in schizophrenia mainly through facilitation of endocannabinoid signalling and cannabinoid receptor type 1 antagonism; (b) cbd administration may exhibit acute anxiolytic effects in patients with generalised social anxiety disorder through modification of cerebral blood flow in specific brain sites and serotonin 1a receptor agonism; (c) cbd may reduce withdrawal symptoms and cannabis/tobacco dependence through modulation of endocannabinoid, serotoninergic and glutamatergic systems; (d) the preclinical pro-cognitive effects of cbd still lack significant results in psychiatric disorders. |
2018-11-06 |
2023-08-13 |
Not clear |
| A Adibfar, M Saleem, K L Lanctot, N Herrman. Potential Biomarkers for Depression Associated with Coronary Artery Disease: A Critical Review. Current molecular medicine. vol 16. issue 2. 2016-10-31. PMID:26812919. |
biomarkers related to hypothalamicpituitary- adrenal axis dysregulation, inflammation, endothelial dysfunction, platelet activation and aggregation, serotonin activity, sympathetic nervous system activation, thyroid function, structural and morphological brain abnormalities, genetic variation, lipid metabolism, one-carbon metabolism, endocannabinoid signalling irregularities, and vitamin d deficiency are reviewed. |
2016-10-31 |
2023-08-13 |
Not clear |
| Shervin Ravan, Diana Martinez, Mark Slifstein, Anissa Abi-Dargha. Molecular imaging in alcohol dependence. Handbook of clinical neurology. vol 125. 2016-07-28. PMID:25307582. |
studies of the opiate system have suggested alterations in some subtypes in discrete brain regions, including the ventral striatum, while studies of serotonin have been negative and those of the cannabinoid system have been inconclusive. |
2016-07-28 |
2023-08-13 |
Not clear |
| Jorge Emilio Ortega, Victor Gonzalez-Lira, Igor Horrillo, Mario Herrera-Marschitz, Luis Felipe Callado, J Javier Mean. Additive effect of rimonabant and citalopram on extracellular serotonin levels monitored with in vivo microdialysis in rat brain. European journal of pharmacology. vol 709. issue 1-3. 2013-11-26. PMID:23562616. |
the cannabinoid system has been implicated in control of mood and neural processing of emotional information, and the modulation of serotonin (5-ht) release in the synaptic clefts. |
2013-11-26 |
2023-08-12 |
rat |
| Takayoshi Kib. Relationships between the autonomic nervous system, humoral factors and immune functions in the intestine. Digestion. vol 74. issue 3-4. 2007-08-24. PMID:17351322. |
serotonin, corticotrophin-releasing factor, endogenous cannabinoid system, pathogen associated molecular patterns) of motility, sensitivity and secretion, the effect of altered mucosal inflammation on cytokine and paracrine activation, and neural sensitization, postinfectious disorders, the influence of psychologic stress on gut functioning through alterations in regulatory pathways, and improved accuracy of diagnosis both at the gut and brain level. |
2007-08-24 |
2023-08-12 |
Not clear |
| Helgi B Schi\\xc3\\xb6t. G protein-coupled receptors in regulation of body weight. CNS & neurological disorders drug targets. vol 5. issue 3. 2006-08-18. PMID:16787226. |
in six reviews, the melanocortins system (including mc4 and mc3 receptors, agrp, msh), the npy receptors (including npy-y1, npy-y2, and npy-y5, pyy3-36), the cannabinoid system (including the development of rimonabant), the ghrelin (ghs, growth hormone secretagogue) system, the monoamine gpcrs (including serotonin, adrenergic and histamine receptors), orexin (hypocretin) system and the galanin receptors are covered. |
2006-08-18 |
2023-08-12 |
Not clear |
| H Hermann, G Marsicano, B Lut. Coexpression of the cannabinoid receptor type 1 with dopamine and serotonin receptors in distinct neuronal subpopulations of the adult mouse forebrain. Neuroscience. vol 109. issue 3. 2002-04-15. PMID:11823058. |
in summary a distinct pattern is emerging for the cannabinoid system with regard to its colocalization with dopamine and serotonin receptors and, therefore, it is likely that different mechanisms underlie its cross-talk with these neurotransmitter systems. |
2002-04-15 |
2023-08-12 |
mouse |